☰

Nathalie Y. Agar, Ph.D. - Publications

Affiliations: 
2002 Concordia University (Canada), Montreal, QC, Canada 
Area:
Biochemistry
Tree Info Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Sun Y, Alberta JA, Pilarz C, Calligaris D, Chadwick EJ, Ramkissoon SH, Ramkissoon LA, Garcia VM, Mazzola E, Goumnerova L, Kane M, Yao Z, Kieran MW, Ligon KL, Hahn WC, ... ... Agar NY, et al. A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas. Neuro-Oncology. PMID 28082416 DOI: 10.1093/Neuonc/Now261  0.323
2016 Sarkaria JN, Calligaris D, Ma D, Parrish K, Mladek AC, Laramy J, Kim M, Zhang S, Schroeder M, Carlson BL, Bakken K, Johnson A, Agar N, Elmquist W. Abstract B25: The critical importance of the blood-brain barrier in modulating the response to otherwise highly effective targeted therapies in patient-derived orthotopic glioblastoma xenografts Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-B25  0.335
2016 Kieran MW, Sun Y, Pilarz C, Calligaris D, Chadwick EJ, Alberta JA, Ramkissoon SH, Ramkissoon LA, Garcia VM, Wilkinson K, Kane M, Goumnerova L, Chi SN, Manley P, Wright KD, ... Agar NY, et al. LG-47TYPE II RAF INHIBITORS INHIBIT BRAF MUTATIONS AND TRUNCATED FUSIONS IN PEDIATRIC LOW-GRADE GLIOMAS Neuro-Oncology. 18: iii89.2-iii89. DOI: 10.1093/Neuonc/Now075.47  0.301
2015 Ma D, Calligaris D, Zhang S, Kim M, Mladek A, Bakken K, Carlson B, Schroeder M, Kitange G, Agar N, Elmquist W, Sarkaria J. DDEL-15MANIPULATION OF THE BLOOD-BRAIN-BARRIER RESTORES THE EFFICACY OF MDM2 INHIBITION IN ORTHOTOPIC GLIOBLASTOMA MODELS Neuro-Oncology. 17: v76.3-v76. DOI: 10.1093/Neuonc/Nov212.15  0.333
2014 Jonas O, Sengupta S, Calligaris D, Poe M, Methuku K, Francois JP, Cook J, Agar N, Pomeroy S, Langer R. ET-24 * A NOVEL TROJAN HORSE FOR IN-VIVO SENSITIVITY TESTING OF MEDULLOBLASTOMA THERAPIES Neuro-Oncology. 16: v84-v84. DOI: 10.1093/Neuonc/Nou255.24  0.309
2013 Colbert CL, Agar NY, Kumar P, Chakko MN, Sinha SC, Powlowski JB, Eltis LD, Bolin JT. Structural characterization of Pandoraea pnomenusa B-356 biphenyl dioxygenase reveals features of potent polychlorinated biphenyl-degrading enzymes. Plos One. 8: e52550. PMID 23308114 DOI: 10.1371/Journal.Pone.0052550  0.496
2008 Master ER, Agar NY, Gómez-Gil L, Powlowski JB, Mohn WW, Eltis LD. Biphenyl dioxygenase from an arctic isolate is not cold adapted. Applied and Environmental Microbiology. 74: 3908-11. PMID 18424535 DOI: 10.1128/Aem.02928-07  0.489
Show low-probability matches.